Capitulo 11_Bladder Cancer - From Basic Science to Robotic Surgery
The Medical Need for an Immune Scoring/Profiling for Melanoma and Other Cancer Patients
Understanding Renal Cell Carcinoma
Mechanism of resistance to target therapy
FISH IN MYELOMA
Reversing immune dysfunction in cancer: novel treatment paradigms
Optimizing Chemotherapy For Malignant Glioma
BR.21 Study Design *2:1 Randomization R Stratified by: Centre PS, 0/1 vs 2/3 Response to prior Rx (CR/PR:SD:PD) Prior regimens, (1 vs 2) Prior platinum,
HEREDITARY BREAST CANCER IN DEVELOPING COUNTRIES Richard G. Pestell, MD, PhD Kimmel Cancer Center Jefferson University Hospital.
P53 E TUMORE MAMMARIO Paolo Radice ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE Milan, Italy Prospettive.
Gut microbiome: debugging the obesity and cancer link Overview Carrie R. Daniel-MacDougall, PhD, MPH Department of Epidemiology Division of Cancer Prevention.
The influence of disulfiram complex with copper (CuEt) on cellular proteasome in breast cancer cell lines Skrott Z 1*, Dou QP 2, Cvek B 1, 1 Department.
